Login / Signup

Disproportionality analysis in VigiBase as a drug repositioning method for the discovery of potentially useful drugs in Alzheimer's disease.

Basile ChrétienJean-Pierre JourdanAudrey DavisSophie FedrizziRonan BureauMarion SassierChristophe RochaisJoachim AlexandreVéronique Lelong-BoulouardCharles DolladillePatrick Dallemagne
Published in: British journal of clinical pharmacology (2020)
We identified 4 drugs with repositioning potential in AD using drug safety profiles derived from a pharmacovigilance database. This method could be useful for future drug repositioning efforts.
Keyphrases
  • adverse drug
  • drug induced
  • high throughput
  • emergency department
  • cognitive decline
  • climate change
  • single cell